Anderson CJ - Search Results

1

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.

Ping Li W, Meyer LA, Capretto DA, Sherman CD, Anderson CJ. Ping Li W, et al. Among authors: anderson cj. Cancer Biother Radiopharm. 2008 Apr;23(2):158-71. doi: 10.1089/cbr.2007.0444. Cancer Biother Radiopharm. 2008. PMID: 18454685 Free article.

2

Copper-64-labeled antibodies for PET imaging.

Anderson CJ, Connett JM, Schwarz SW, Rocque PA, Guo LW, Philpott GW, Zinn KR, Meares CF, Welch MJ. Anderson CJ, et al. J Nucl Med. 1992 Sep;33(9):1685-91. J Nucl Med. 1992. PMID: 1517844 Free article.

3

Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.

Anderson CJ, Schwarz SW, Connett JM, Cutler PD, Guo LW, Germain CJ, Philpott GW, Zinn KR, Greiner DP, Meares CF, et al. Anderson CJ, et al. J Nucl Med. 1995 May;36(5):850-8. J Nucl Med. 1995. PMID: 7738663 Free article.

4

Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.

Cutler PD, Schwarz SW, Anderson CJ, Connett JM, Welch MJ, Philpott GW, Siegel BA. Cutler PD, et al. Among authors: anderson cj. J Nucl Med. 1995 Dec;36(12):2363-71. J Nucl Med. 1995. PMID: 8523133 Free article.

5

Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.

Connett JM, Anderson CJ, Guo LW, Schwarz SW, Zinn KR, Rogers BE, Siegel BA, Philpott GW, Welch MJ. Connett JM, et al. Among authors: anderson cj. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6814-8. doi: 10.1073/pnas.93.13.6814. Proc Natl Acad Sci U S A. 1996. PMID: 8692901 Free PMC article.

6

Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.

Rogers BE, Anderson CJ, Connett JM, Guo LW, Edwards WB, Sherman EL, Zinn KR, Welch MJ. Rogers BE, et al. Among authors: anderson cj. Bioconjug Chem. 1996 Jul-Aug;7(4):511-22. doi: 10.1021/bc9600372. Bioconjug Chem. 1996. PMID: 8853465

7

Efficient production of high specific activity 64Cu using a biomedical cyclotron.

McCarthy DW, Shefer RE, Klinkowstein RE, Bass LA, Margeneau WH, Cutler CS, Anderson CJ, Welch MJ. McCarthy DW, et al. Among authors: anderson cj. Nucl Med Biol. 1997 Jan;24(1):35-43. doi: 10.1016/s0969-8051(96)00157-6. Nucl Med Biol. 1997. PMID: 9080473

8

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Lewis JS, et al. Among authors: anderson cj. Nucl Med Biol. 1999 Apr;26(3):267-73. doi: 10.1016/s0969-8051(98)00105-x. Nucl Med Biol. 1999. PMID: 10363797

9

Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model.

Connett JM, Buettner TL, Anderson CJ. Connett JM, et al. Among authors: anderson cj. Clin Cancer Res. 1999 Oct;5(10 Suppl):3207s-3212s. Clin Cancer Res. 1999. PMID: 10541365

10

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.

Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwarz SW, Morris MM, Miller JP, Anderson CJ. Lewis JS, et al. Among authors: anderson cj. Clin Cancer Res. 1999 Nov;5(11):3608-16. Clin Cancer Res. 1999. PMID: 10589778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters